Zhou Chen, Qi Wei, Lewis E Neil, Randolph Theodore W, Carpenter John F
Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045.
Malvern Instruments, Columbia, Maryland 21046.
J Pharm Sci. 2016 Aug;105(8):2302-9. doi: 10.1016/j.xphs.2016.05.013. Epub 2016 Jun 9.
The first goal of this study was to determine the effects of the surface fraction of protein in lyophilized formulations of intravenous immunoglobulin on protein stability during long-term storage. We attempted to modulate surface fraction by either including polysorbate 20 (PS20) in the formulation or performing pre-drying annealing during lyophilization, but neither approach reduced surface fraction. Our second goal was to study the effects of formulation and processing conditions on protein aggregation and subvisible particle formation. If formulations were reconstituted immediately after lyophilization, protein aggregation detected by size exclusion chromatography was insignificant. However, with the higher resolution of damage afforded by subvisible particle analysis, it was found that high levels of particles were produced in the formulation containing trehalose and that the presence of PS20 greatly reduced particle concentrations. Size exclusion chromatography analysis showed that in formulations without trehalose during storage for 16 weeks at 50°C, there was loss of monomer and a concomitant increase in aggregates. In formulations containing trehalose there were no significant increases in aggregation or subvisible particle levels. Finally, we observed that inclusion of PS20 in the water used to reconstitute lyophilized formulations without PS20 reduced the formation of protein particles; documenting that protection by the surfactant occurred during reconstitution as well as during lyophilization.
本研究的首要目标是确定静脉注射免疫球蛋白冻干制剂中蛋白质的表面分数对长期储存期间蛋白质稳定性的影响。我们试图通过在制剂中加入聚山梨酯20(PS20)或在冻干过程中进行预干燥退火来调节表面分数,但这两种方法均未降低表面分数。我们的第二个目标是研究制剂和加工条件对蛋白质聚集和亚可见颗粒形成的影响。如果冻干后立即复溶制剂,通过尺寸排阻色谱法检测到的蛋白质聚集并不明显。然而,随着亚可见颗粒分析提供的更高损伤分辨率,发现含有海藻糖的制剂中产生了大量颗粒,并且PS20的存在大大降低了颗粒浓度。尺寸排阻色谱分析表明,在不含海藻糖的制剂于50°C储存16周期间,单体有所损失,同时聚集体增加。在含有海藻糖的制剂中,聚集或亚可见颗粒水平没有显著增加。最后,我们观察到在用于复溶不含PS20的冻干制剂的水中加入PS20可减少蛋白质颗粒的形成;证明表面活性剂在复溶过程以及冻干过程中均起到了保护作用。